Literature DB >> 23388888

Biphasic Erk1/2 activation sequentially involving Gs and Gi signaling is required in beta3-adrenergic receptor-induced primary smooth muscle cell proliferation.

Tarik Hadi1, Marina Barrichon, Pascal Mourtialon, Maeva Wendremaire, Carmen Garrido, Paul Sagot, Marc Bardou, Frédéric Lirussi.   

Abstract

The beta3 adrenergic receptor (B3-AR) reportedly induces cell proliferation, but the signaling pathways that were proposed, involving either Gs or Gi coupling, remain controversial. To further investigate the role of G protein coupling in B3-AR induced proliferation, we stimulated primary human myometrial smooth muscle cells with SAR150640 (B3-AR agonist) in the absence or presence of variable G-protein inhibitors. Specific B3-AR stimulation led to an Erk1/2 induced proliferation. We observed that the proliferative effects of B3-AR require two Erk1/2 activation peaks (the first after 3min, the second at 8h). Erk1/2 activation at 3min was mimicked by forskolin (adenylyl-cyclase activator), and was resistant to pertussis toxin (Gi inhibitor), suggesting a Gs protein signaling. This first signaling also required the downstream Gs signaling effectors PKA and Src. However, Erk1/2 activation at 8h turned out to be pertussis toxin-dependent, and PKA-independent, indicating a Gi signaling pathway in which Src and PI3K were required. The pharmacological inhibition of both the Gs and Gi pathway abolished B3-AR-induced proliferation. Altogether, these data indicate that B3-AR-induced proliferation depends on the biphasic activation of Erk1/2 sequentially induced by the Gs/PKA/Src and Gi/Src/PI3K signaling pathways.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388888     DOI: 10.1016/j.bbamcr.2013.01.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Authors:  Katerina Okeke; Stephane Angers; Michel Bouvier; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

2.  Denominator changes may obscure results from single-well assays: β3-adrenoceptor ligand-induced changes of cell number as example.

Authors:  Katerina Okeke; Martina B Michel-Reher; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-04       Impact factor: 3.000

3.  Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by Gs and Gi/o Proteins.

Authors:  Susanne Neumann; Sarah S Malik; Bernice Marcus-Samuels; Elena Eliseeva; Daesong Jang; Joanna Klubo-Gwiezdzinska; Christine C Krieger; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2019-11-08       Impact factor: 4.436

4.  Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells.

Authors:  Marina Barrichon; Tarik Hadi; Maeva Wendremaire; Clémentine Ptasinski; Renaud Seigneuric; Guillaume Marcion; Marc Delignette; Jacques Marchet; Monique Dumas; Paul Sagot; Marc Bardou; Carmen Garrido; Frédéric Lirussi
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

5.  Inhibitory signaling in mammalian olfactory transduction potentially mediated by Gαo.

Authors:  Elizabeth A Corey; Kirill Ukhanov; Yuriy V Bobkov; Jeremy C McIntyre; Jeffrey R Martens; Barry W Ache
Journal:  Mol Cell Neurosci       Date:  2020-12-25       Impact factor: 4.626

6.  Regulation of bFGF-induced effects on rat aortic smooth muscle cells by β3-adrenergic receptors.

Authors:  Yingzi Chang; Lei Alena Dagat; Aisha Yusuf; Yusuf Zahriya; Kotryna Staputyte; Emma Worley; Alex Holt; Natalie Canuteson; Vereena Messieha; Kasey Halila
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-03-07

7.  Title: β3 Adrenergic Receptor Signaling in the Human Myometrium.

Authors:  Hazik Asif; Scott D Barnett; Iain L O Buxton
Journal:  Reprod Sci       Date:  2022-04-04       Impact factor: 2.924

8.  Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.

Authors:  Qingtong Wang; Ying Wang; Toni M West; Yongming Liu; Gopireddy R Reddy; Federica Barbagallo; Bing Xu; Qian Shi; Bingqing Deng; Wei Wei; Yang K Xiang
Journal:  Cardiovasc Res       Date:  2021-08-29       Impact factor: 10.787

9.  Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate.

Authors:  Ru Huang; Yuhan Liu; Anna Ciotkowska; Alexander Tamalunas; Raphaela Waidelich; Frank Strittmatter; Christian G Stief; Martin Hennenberg
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.